Home›Companies›Algen Biotechnologies
Algen Biotechnologies

Using CRISPR to find treatments for cancer and inflammation

Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR gene-modulation and frontier AI to find drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
Active Founders
Chun-Hao Huang
Chun-Hao Huang
Founder/CEO
Dr. Huang is Co-Founder and CEO of Algen, with the mission to revolutionize therapeutic discovery through CRISPR gene-modulation and frontier AI. A genetic engineer, drug developer and AI entrepreneur, he received postdoc fellow at UC Berkeley under Nobel Laureate Jennifer Doudna and pioneered disease-relevant models using CRISPR. Dr. Huang’s accolades include an Edison Award, TIME Best Inventions of 2026, and being named a Lindau Nobel Laureate Meeting Fellow and Innovators Under 35.
Co-Founder and CBO, Algen
Algen Biotechnologies
Founded:2018
Batch:Winter 2020
Team Size:17
Status:
Active
Location:San Francisco